d-alpha tocopherol has been researched along with deoxycytidine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bartsch, H; Becker, N; Hagenlocher, T; Korfmann, A; Nair, J | 1 |
| Erkisi, M; Kara, IO; Sahin, B | 1 |
| Hildebrand, J | 1 |
| Brand, RE; Singh, SV; Stan, SD | 1 |
| Aggarwal, BB; Deorukhkar, A; Dey, S; Diagaradjane, P; Gelovani, JG; Guha, S; Koca, C; Krishnan, S; Kunnumakkara, AB; Ravindran, J; Sung, B; Tong, Z; Yadav, VR | 1 |
| Francois, RA; Husain, K; Malafa, MP; Perez, M; Sebti, SM; Yamauchi, T | 1 |
| Fong, CW; Kumar, AP; Li, F; Manu, KA; Ramachandran, L; Sethi, G; Shanmugam, MK; Tan, P | 1 |
| Centeno, BA; Chen, DT; Hingorani, SR; Husain, K; Malafa, MP; Sebti, SM | 1 |
| Dai, X; Fan, W; Katragadda, U; Mckinley, D; Tan, C; Teng, Q; Wang, Y | 1 |
| Antunes Soares, FA; Araújo, Mdo C; Baldissareli, J; Belmonte Pereira, L; Bitencourt Rosa Leal, D; Brenner Reetz, LG; Chiesa, J; Curry Martins, C; Morsch, VM; Pelinson, LP; Pires Amaral, G; Schetinger, MR; Schmatz, R; Zanini, D | 1 |
| Chang, C; Guo, H; Huang, X; Li, M; Lu, Q; Xie, B; Yan, J; Yan, X; Yao, X; Ye, C; Zhang, Z; Zhao, W; Zhou, J; Zhuang, J | 1 |
| Du, F; Huang, J; Liu, S; Lu, W; Meng, H; Xu, Y; Yu, J | 1 |
| Abu-Fayyad, A; Nazzal, S | 1 |
| Alzhrani, RF; Cui, Z; Lansakara-P, DSP; Rodriguez, A; Thakkar, SG; Valdes, SA | 1 |
| Chen, G; Li, H; Liu, M; Lu, W; Svirskis, D; Wen, J; Ying, M | 1 |
2 review(s) available for d-alpha tocopherol and deoxycytidine
| Article | Year |
|---|---|
Neurological complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Capecitabine; Central Nervous System; Deoxycytidine; Fluorouracil; Humans; Magnetic Resonance Imaging; Neoplasms; Neuroprotective Agents; Peripheral Nervous System; Peripheral Nervous System Diseases; Vitamin E | 2006 |
Chemoprevention strategies for pancreatic cancer.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Camellia sinensis; Celecoxib; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Disease Models, Animal; Down-Regulation; Drug Synergism; Gemcitabine; Humans; Isothiocyanates; Pancreatic Neoplasms; Phototherapy; Pyrazoles; Sulfonamides; Tea; Vitamin D; Vitamin E | 2010 |
13 other study(ies) available for d-alpha tocopherol and deoxycytidine
| Article | Year |
|---|---|
Influence of dietary fatty acid, vegetable, and vitamin intake on etheno-DNA adducts in white blood cells of healthy female volunteers: a pilot study.
Topics: Adult; Antioxidants; beta Carotene; Deoxyadenosines; Deoxycytidine; Diet; DNA Adducts; Fatty Acids; Female; Humans; Leukocytes; Linoleic Acid; Lipid Peroxidation; Middle Aged; Oleic Acid; Oxidative Stress; Pilot Projects; Vegetables; Vitamin E; Vitamins | 2001 |
Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Docetaxel; Erythema; Fatal Outcome; Female; Fluorouracil; Foot; Hand; Humans; Middle Aged; Paresthesia; Taxoids; Vitamin E | 2006 |
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Proliferation; Chromans; Cyclooxygenase 2; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Inflammation; Inflammation Mediators; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2010 |
Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, SCID; Models, Biological; NF-kappa B; Pancreatic Neoplasms; Up-Regulation; Vitamin E; Xenograft Model Antitumor Assays | 2011 |
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Capecitabine; Cell Line, Tumor; Cell Proliferation; Chromans; Cyclin D1; Cyclooxygenase 2; Deoxycytidine; Disease Models, Animal; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Intercellular Adhesion Molecule-1; Ki-67 Antigen; Matrix Metalloproteinase 9; Mice; Mice, Nude; Mitochondria; Neovascularization, Pathologic; NF-kappa B; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-bcl-2; Receptors, CXCR4; Repressor Proteins; Stomach Neoplasms; Survivin; Vascular Endothelial Growth Factor A; Vitamin E; Xenograft Model Antitumor Assays | 2012 |
Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Body Weight; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Deoxycytidine; Disease Models, Animal; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Genes, ras; Genotype; Immunohistochemistry; Male; Mice; Mice, Transgenic; Pancreatic Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Poly(ADP-ribose) Polymerases; Random Allocation; Signal Transduction; Treatment Outcome; Vitamin E | 2013 |
Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
Topics: Animals; Antimetabolites, Antineoplastic; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Cytidine Deaminase; Deoxycytidine; Drug Delivery Systems; Female; Gemcitabine; Humans; Mice; Micelles; Phosphatidylethanolamines; Polyethylene Glycols; Vitamin E; Xenograft Model Antitumor Assays | 2014 |
δ-Aminolevulinate dehydratase activity in lung cancer patients and its relationship with oxidative stress.
Topics: Aged; Ascorbic Acid; Blood Platelets; Case-Control Studies; Catalase; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Oxidative Stress; Porphobilinogen Synthase; Reactive Oxygen Species; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2014 |
δ-tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein-Tyrosine Kinases; Signal Transduction; STAT3 Transcription Factor; Urinary Bladder Neoplasms; Vitamin E | 2015 |
Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
Topics: alpha-Tocopherol; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Stability; Drug Storage; Female; Gemcitabine; Humans; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyethylene Glycols; Prodrugs; Vitamin E | 2015 |
Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromans; Deamination; Deoxycytidine; Gemcitabine; Humans; Nanoparticles; Tocotrienols; Vitamin E | 2017 |
A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Lecithins; Lipids; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyethylene Glycols; Solubility; Vitamin E | 2019 |
N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Deoxycytidine; Drug Carriers; Drug Liberation; Gemcitabine; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Vitamin E | 2021 |